Skip to content

FAPI PET Imaging for Non-invasive Assessment of Endometriosis: A Clinical Study

FAPI PET Imaging for Non-invasive Assessment of Endometriosis: A Clinical Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600118361
Enrollment
Unknown
Registered
2026-02-04
Start date
2026-02-04
Completion date
Unknown
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis

Interventions

Gold Standard:The results of laparoscopic surgery or biopsy histopathology were used as the gold standard.
Index test:SUVmax and SUVmean of the lesion, target-to-background ratio (TBR), AUC value, sensitivity, specificity, and lesion detection rate

Sponsors

Renji Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1) Women of childbearing age between 18 and 45 years old 2) Clinically suspected (with symptoms) or diagnosed with endometriosis based on traditional imaging methods 3) Planning to undergo therapeutic laparoscopic surgery 4) Capable of understanding and providing written informed consent

Exclusion criteria

Exclusion criteria: 1) Pregnant women or lactating women 2) Known to be allergic to the 18F-FAPI imaging agent. 3) Have a history of other malignant tumors or have multiple primary malignant tumors. 4) Postoperative pathology confirmed as non-endometriosis.

Design outcomes

Primary

MeasureTime frame
The detection rate of lesions;Sensitivity;Specificity;The range, size, boundary or total uptake of the lesion;SUVmax/SUVmean;Target Background Ratio ;AUC;

Countries

China

Contacts

Public ContactJianjun Liu;Taiyang Ye

Renji Hospital, Shanghai Jiao Tong University School of Medicine

nuclearj@163.com+86 133 0182 6638

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026